See also this year's filing and all EDGAR filings for this company.
PDF Report 0001069308_2015_Acer_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001069308', 'EntityCommonStockSharesOutstanding': 6864340, 'Assets': 14416698, 'AssetsCurrent': 13578831, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 4801436, 'LiabilitiesAndStockholdersEquity': 14416698, 'LiabilitiesCurrent': 4801436, 'LiabilitiesNoncurrent': 0, 'NetIncome': -12019278, 'PropertyPlantAndEquipmentNet': 837867, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 9615262, 'remainder_NetIncome': -12019278, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001069308, Acer Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 10,665,316 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,098,104 |
| 3 | remainder_Assets | 38,939 |
| 4 | LiabilitiesCurrent | 3,132,424 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 1,230,748 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 1,983 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -15,050,280 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 11,802,359 |
| 1 | Liabilities | 4,363,172 |
| 2 | Expenses | 1,983 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 7,439,187 |
| 5 | NetIncome | -15,052,263 |
| 6 | ComprehensiveNetIncome | -15,052,263 |
| 7 | BaseVar | 15,608,897 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.144 |
| 9 | EconomicCapitalRatio | 1.55 |